Industry Projects
Fall '23: Latham Biopharm Group
The purpose of our project with Latham Biopharm Group was to identify to identify market gap opportunities within the digital health consulting space. We estimated the growth of digital solutions within the molecular diagnostics and digital diagnostics sectors as well as provided go-to-market recommendations for the company.
Spring '23: Sensal Health
The purpose of our project with Sensal Health is to identify opportunities for technological innovation within the medication adherence market space. We are using multiple markets to estimate the growth potential of the market of interest. This will be followed by key opinion leader (KOL) outreach to understand and validate customer needs. Currently, our mid-project update is to remain confidential via a Non-disclosure Agreement (NDA).
Fall '22: Novozymes
The purpose of my team's project with Novozymes was to identify and analyze gap markets within the United States market sector. We used multiple market databases to identify potential gaps in Novozymes' USA portfolio. This was followed by key opinion leader (KOL) outreach to understand and validate customer needs. Currently, our mid-project update and final presentations are confidential via a Confidential Disclosure Agreement (CDA).
